Tennessee House Bill HB2049

Tennessee 2025-2026 Regular Session

• Introduced: 1/23/26
• Refer: 2/4/26

Caption

AN ACT to amend Tennessee Code Annotated, Title 4; Title 63 and Title 68, relative to the state uterine fibroids commission.

Impact

The bill introduces a framework for addressing the healthcare needs of women impacted by uterine fibroids and related conditions, specifically by establishing an advisory body to the governor and the Department of Health. This commission will be empowered to research state regulations, review treatment protocols, and ultimately make recommendations to enhance public health strategies. Such measures reflect broader legislative efforts to improve health outcomes for women, indicating a potential shift in how these health issues were previously managed within the state.

Summary

House Bill 2049 aims to establish a state uterine fibroids commission in Tennessee, focusing on the challenges faced by women suffering from uterine fibroids, polycystic ovary syndrome, and endometriosis. Through this commission, which will consist of eleven members appointed by various authorities, including the governor and legislative leaders, the bill seeks to provide a structured approach to address these health issues and improve public health outcomes in the state. The commission is charged with evaluating the functions of existing organizations addressing these conditions and facilitating collaboration among stakeholders.

Contention

Though the bill seems to have a well-intentioned focus on improving women's health, discussions about its implications could spark contention among different interest groups. Critics may raise concerns regarding the provision of adequate funding and resources to ensure the commission can effectively fulfill its mandate. Additionally, some may argue about the representation on the commission, questioning if the appointed members sufficiently reflect the experiences of women affected by uterine fibroids and related health conditions.